Style | Citing Format |
---|---|
MLA | Moradi S, et al.. "Effects of Spirulina Supplementation in Patients With Ulcerative Colitis: A Double-Blind, Placebo-Controlled Randomized Trial." BMC Complementary Medicine and Therapies, vol. 24, no. 1, 2024, pp. -. |
APA | Moradi S, Bagheri R, Amirian P, Zarpoosh M, Cheraghloo N, Wong A, Zobeiri M, Entezari MH (2024). Effects of Spirulina Supplementation in Patients With Ulcerative Colitis: A Double-Blind, Placebo-Controlled Randomized Trial. BMC Complementary Medicine and Therapies, 24(1), -. |
Chicago | Moradi S, Bagheri R, Amirian P, Zarpoosh M, Cheraghloo N, Wong A, Zobeiri M, Entezari MH. "Effects of Spirulina Supplementation in Patients With Ulcerative Colitis: A Double-Blind, Placebo-Controlled Randomized Trial." BMC Complementary Medicine and Therapies 24, no. 1 (2024): -. |
Harvard | Moradi S et al. (2024) 'Effects of Spirulina Supplementation in Patients With Ulcerative Colitis: A Double-Blind, Placebo-Controlled Randomized Trial', BMC Complementary Medicine and Therapies, 24(1), pp. -. |
Vancouver | Moradi S, Bagheri R, Amirian P, Zarpoosh M, Cheraghloo N, Wong A, et al.. Effects of Spirulina Supplementation in Patients With Ulcerative Colitis: A Double-Blind, Placebo-Controlled Randomized Trial. BMC Complementary Medicine and Therapies. 2024;24(1):-. |
BibTex | @article{ author = {Moradi S and Bagheri R and Amirian P and Zarpoosh M and Cheraghloo N and Wong A and Zobeiri M and Entezari MH}, title = {Effects of Spirulina Supplementation in Patients With Ulcerative Colitis: A Double-Blind, Placebo-Controlled Randomized Trial}, journal = {BMC Complementary Medicine and Therapies}, volume = {24}, number = {1}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Moradi S AU - Bagheri R AU - Amirian P AU - Zarpoosh M AU - Cheraghloo N AU - Wong A AU - Zobeiri M AU - Entezari MH TI - Effects of Spirulina Supplementation in Patients With Ulcerative Colitis: A Double-Blind, Placebo-Controlled Randomized Trial JO - BMC Complementary Medicine and Therapies VL - 24 IS - 1 SP - EP - PY - 2024 ER - |